What is NCT04512345, and is it testing roflumilast?
I can’t answer this accurately from the information provided. Your question asks whether the clinical trial with identifier NCT04512345 is testing roflumilast, but no trial details (title, drug, sponsor, indication, or status) were included here, and I don’t have access to look up the NCT record in this chat.
If you paste the trial’s title/sponsor line or the “Intervention(s)” section text from the NCT page, I can tell you whether roflumilast is the study drug and summarize the study’s purpose, design, and status.
How to check quickly whether NCT04512345 is a roflumilast trial
On the ClinicalTrials.gov page for NCT04512345, look for:
- “Intervention(s)” → the listed drug name (roflumilast would appear here if it’s being tested)
- “Condition or disease” → helps confirm the therapy context
- “Brief Summary” / “Study Description” → often repeats the drug name
- “Official Title” → sometimes includes the drug in the title
What I can summarize once you share the trial text
If you provide the “Intervention(s)” and “Study Status” lines, I can summarize:
- study phase (e.g., Phase 1/2/3)
- participants and key inclusion criteria (if shown)
- dosing/regimen (if listed)
- primary outcomes/endpoints
- recruitment status and estimated completion (if present)
If you meant “roflumilast clinical trial NCT…”, which details do you have?
Reply with either:
1) the link to the ClinicalTrials.gov page for NCT04512345, or
2) a copy/paste of the “Intervention(s)” section, or
3) the trial’s title and condition.
Then I’ll confirm whether roflumilast is included and summarize the trial’s clinical focus.